[HTML][HTML] State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Background The incidence of secondary pulmonary infections is not well described in
hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary …
hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary …
Pathogenesis of respiratory viral and fungal coinfections
Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …
[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …
J Prattes, J Wauters, DR Giacobbe… - Clinical Microbiology …, 2022 - Elsevier
Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …
Coronavirus disease 2019–associated invasive fungal infection
JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …
Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review
WH Chong, KP Neu - Journal of Hospital Infection, 2021 - Elsevier
Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …
[HTML][HTML] Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
AK Johnson, Z Ghazarian, KD Cendrowski… - Medical mycology case …, 2021 - Elsevier
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal
infections. Most documented cases have been reported in patients with diabetes mellitus …
infections. Most documented cases have been reported in patients with diabetes mellitus …
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
JP Gangneux, E Dannaoui, A Fekkar… - The Lancet …, 2022 - thelancet.com
Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …
[HTML][HTML] A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …
[HTML][HTML] Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary
aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …
aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …
Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: a systematic review and meta‐analysis
Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …
worldwide. However, basic epidemiological characteristics have not been well established …